Razupenem

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameRazupenem
Drug Alias Name阿祖培南PZ-601PTZ-601SMP-601SM-216601 +[6] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell wall inhibitors
TargetsPeripheral benzodiazepine receptor
Therapy Area/IndicationsSkin Diseases, Infectious
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSumitomo Dainippon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtez Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSkin Diseases, Infectious

Other Information

ATC CodeN/A
Related LinksN/A